HighTower Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.49M Buy
96,325
+8,580
+10% +$133K ﹤0.01% 1746
2025
Q1
$1.3M Sell
87,745
-36,694
-29% -$546K ﹤0.01% 1784
2024
Q4
$1.65M Buy
124,439
+1,852
+2% +$24.5K ﹤0.01% 1629
2024
Q3
$1.74M Buy
122,587
+81,653
+199% +$1.16M ﹤0.01% 1603
2024
Q2
$532K Sell
40,934
-52,123
-56% -$677K ﹤0.01% 2272
2024
Q1
$1.3M Buy
93,057
+8,787
+10% +$122K ﹤0.01% 1650
2023
Q4
$1.21M Buy
84,270
+550
+0.7% +$7.88K ﹤0.01% 1734
2023
Q3
$1.3M Buy
83,720
+12,423
+17% +$193K ﹤0.01% 1613
2023
Q2
$1.12M Buy
71,297
+38,651
+118% +$605K ﹤0.01% 1694
2023
Q1
$523K Buy
32,646
+6,204
+23% +$99.4K ﹤0.01% 2066
2022
Q4
$414K Buy
26,442
+3,015
+13% +$47.2K ﹤0.01% 2241
2022
Q3
$304K Sell
23,427
-719
-3% -$9.33K ﹤0.01% 2316
2022
Q2
$340K Sell
24,146
-4,180
-15% -$58.9K ﹤0.01% 2259
2022
Q1
$404K Buy
28,326
+1,973
+7% +$28.1K ﹤0.01% 2308
2021
Q4
$360K Sell
26,353
-5,260
-17% -$71.9K ﹤0.01% 2350
2021
Q3
$512K Sell
31,613
-611
-2% -$9.9K ﹤0.01% 2036
2021
Q2
$544K Buy
32,224
+5,666
+21% +$95.7K ﹤0.01% 2002
2021
Q1
$485K Buy
26,558
+3,694
+16% +$67.5K ﹤0.01% 1988
2020
Q4
$416K Sell
22,864
-1,734
-7% -$31.5K ﹤0.01% 1705
2020
Q3
$440K Buy
24,598
+889
+4% +$15.9K ﹤0.01% 1622
2020
Q2
$425K Buy
23,709
+4,694
+25% +$84.1K ﹤0.01% 1533
2020
Q1
$293K Buy
19,015
+3,395
+22% +$52.3K ﹤0.01% 1567
2019
Q4
$309K Sell
15,620
-454
-3% -$8.98K ﹤0.01% 1698
2019
Q3
$275K Sell
16,074
-13,865
-46% -$237K ﹤0.01% 1846
2019
Q2
$534K Buy
29,939
+919
+3% +$16.4K ﹤0.01% 1484
2019
Q1
$591K Buy
+29,020
New +$591K ﹤0.01% 1373